Infectious agents and lymphoma development: Molecular and clinical aspects

Journal of Internal Medicine

Volumn 265, Issue 4, 2009, Pages 421-438

  Ferreri, A J M ^a   Ernberg, I ^b   Copie Bergman, C ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Borrelia; Chlamydia psittaci; Epstein Barr virus; Helicobacter pylori; Hodgkin lymphoma; Lymphomagenesis; MALT type lymphoma

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; DOXYCYCLINE; PROTON PUMP INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANTIBIOTIC THERAPY; APOPTOSIS; BORRELIA BURGDORFERI; CELL PROLIFERATION; CHLAMYDIA; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; CHROMOSOME ABERRATION; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; DUODENOSCOPY; ENDOSCOPIC ECHOGRAPHY; EPSTEIN BARR VIRUS; GASTRITIS; GENETIC MARKER; GENETIC SCREENING; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE; VIRULENCE; VIRUS STRAIN;

BORRELIA; BORRELIA INFECTIONS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PSITTACI; CYTOGENETICS; EPSTEIN-BARR VIRUS INFECTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL;

EID: 61849140711     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02083.x     Document Type: Review

References (125)

1. Thieblemont C, Berger F, Dumontet C et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000 95 : 802 6.
2. Ferreri AJ, Guidoboni M, Ponzoni M et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004 96 : 586 94.
3. Goodlad JR, Davidson MM, Hollowood K et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000 24 : 1279 85.
4. Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002 347 : 89 94.
5. Babcock GJ, Hochberg D, Thorley-Lawson AD. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000 13 : 497 506.
6. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984 53 : 2515 24.
7. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France : IARC Press ed., 2008.
8. Doglioni C, Wotherspoon A, Moschini A et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992 339 : 834 5.
9. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994 330 : 1267 71.
10. Zucca E, Bertoni F, Roggero E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998 338 : 804 10.
11. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of low grade B-cell gastric lymphoma of MALT type following eradication of Helicobacter pylori (Meeting abstract). J Pathol 1993 170 (Suppl 335A.
12. Ye H, Liu H, Attygalle A et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003 102 : 1012 8.
13. Delchier JC, Lamarque D, Levy M et al. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am J Gastroenterol 2001 96 : 2324 8.
14. Lehours P, Menard A, Dupouy S et al. Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun 2004 72 : 880 8.
15. Lehours P, Dupouy S, Bergey F et al. Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. Gut 2004 53 : 931 7.
16. Rollinson S, Levene AP, Mensah FK et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003 102 : 1007 11.
17. Wu MS, Shun CT, Huang SP et al. Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica 2004 89 : 1015 7.
18. Hellmig S, Vollenberg S, Goebeler-Kolve ME et al. IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood 2004 104 : 2994 5.
19. Wu YY, Tsai JT, Lin JT et al. Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. World J Gastroenterol 2004 10 : 2334 9.
20. Hellmig S, Fischbach W, Goebeler-Kolve ME et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol 2005 100 : 2644 9.
21. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993 342 : 571 4.
22. D'Elios MM, Amedei A, Manghetti M et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori- related gastric low-grade MALT lymphoma. Gastroenterology 1999 117 : 1105 12.
23. Schmees C, Prinz C, Treptau T et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 2007 132 : 1820 33.
24. Cheng TY, Lin JT, Chen LT et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2006 24 : 3483 9.
25. Levy M, Copie-Bergman C, Traulle C et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002 97 : 292 7.
26. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 1977 153 : 218 21.
27. Rohatiner A, D'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994 5 : 397 400.
28. Du MQ. MALT lymphoma : recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007 47 : 31 42.
29. Zhou Y, Ye H, Martin-Subero JI et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006 133 : 35 42.
30. Liu H, Ye H, Ruskone-Fourmestraux A et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002 122 : 1286 94.
31. Nakamura S, Ye H, Bacon CM et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007 56 : 1358 63.
32. Ye H, Gong L, Liu H et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut 2006 55 : 137 8.
33. Ye H, Remstein ED, Bacon CM et al. Chromosomal translocations involving BCL6 in MALT lymphoma. Haematologica 2008 93 : 145 6.
34. Streubel B, Vinatzer U, Lamprecht A et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005 19 : 652 8.
35. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007 56 : 1685 7.
36. Copie-Bergman C, Locher C, Levy M et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol 2005 16 : 1232 6.
37. Copie-Bergman C, Wotherspoon A. MALT Lymphoma Pathology, Initial Diagnosis, and Posttreatment Evaluation. London, UK : Healthcare I, 2008.
38. Raderer M, Streubel B, Wohrer S et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006 55 : 616 8.
39. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007 136 : 521 38.
40. Levy M, Copie-Bergman C, Gameiro C et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005 23 : 5061 6.
41. Margo CE, Mulla ZD. Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology 1998 105 : 185 90.
42. Moslehi R, Devesa SS, Schairer C, Fraumeni C. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst 2006 98 : 936 9.
43. Ferreri AJ, Dolcetti R, Du MQ et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 2008 19 : 835 46.
44. Sarraf D, Jain A, Dubovy S et al. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina 2005 25 : 94 8.
45. Mannami T, Yoshino T, Oshima K et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001 14 : 641 9.
46. Coupland SE, Foss HD, Anagnostopoulos I et al. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa. Invest Ophthalmol Vis Sci 1999 40 : 555 62.
47. Hara Y, Nakamura N, Kuze T et al. Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma. Invest Ophthalmol Vis Sci 2001 42 : 2450 7.
48. Remstein ED, Kurtin PJ, James CD et al. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 2002 161 : 63 71.
49. Streubel B, Huber L, Wohrer S et al. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren's syndrome. Clin Cancer Res 2004 10 : 476 80.
50. Matteucci C, Galieni P, Leoncini L et al. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol 2003 200 : 656 60.
51. Martinet S, Ozsahin M, Belkacemi Y et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003 55 : 892 8.
52. Rosado MF, Byrne JG, Ding F et al. Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2005 107 : 467 72.
53. Matsuo T, Yoshino T. Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. Ophthalmology 2004 111 : 1233 7.
54. Tanimoto K, Kaneko A, Suzuki S et al. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 2006 17 : 135 40.
55. Ejima Y, Sasaki R, Okamoto Y et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 2006 78 : 6 9.
56. Tsang RW, Gospodarowicz M. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol 2005 23 : 10 7.
57. Ben Simon GJ, Cheung N, Mckelvie P et al. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology 2006 113 : 1209 13.
58. Sasai K, Yamabe H, Dodo Y et al. Non-Hodgkin's lymphoma of the ocular adnexa. Acta Oncol 2001 40 : 485 90.
59. Ferreri AJ, Ponzoni M, Martinelli G et al. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 2005 90 : 1578 9.
60. Blasi MA, Gherlinzoni F, Calvisi G et al. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 2001 108 : 559 62.
61. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996 2 : 307 19.
62. Nasisse MP, Guy JS, Stevens JB et al. Clinical and laboratory findings in chronic conjunctivitis in cats: 91 cases (1983-1991). J Am Vet Med Assoc 1993 203 : 834 7.
63. Lietman T, Brooks D, Moncada J et al. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis 1998 26 : 1335 40.
64. Byrne GI, Ojcius DM. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004 2 : 802 8.
65. Koivisto AL, Isoaho R, Von Hertzen L et al. Chlamydial antibodies in an elderly Finnish population. Scand J Infect Dis 1999 31 : 135 9.
66. Ferreri AJ, Dolcetti R, Dognini G et al. Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control study. Int J Cancer 2008 (in press).
67. Ponzoni M, Ferreri AJ, Guidoboni M et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res 2008 14 : 5794 800.
68. Yoo C, Ryu MH, Huh J et al. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Am J Hematol 2007 82 : 821 3.
69. Aigelsreiter A, Leitner E, Deutsch A et al. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Leuk Res 2008 32 : 1292 4.
70. Chanudet E, Zhou Y, Bacon CM et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006 209 : 344 51.
71. Chanudet E, Adam P, Nicholson AG et al. Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma. Br J Cancer 2007 97 : 949 51.
72. Chan CC, Shen D, Mochizuki M et al. Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma. Trans Am Ophthalmol Soc 2006 104 : 62 70.
73. Matthews JM, Moreno LI, Dennis J et al. Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis. Br J Haematol 2008 142 : 246 9.
74. Ferreri AJ, Ponzoni M, Viale E et al. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications. Hematol Oncol 2006 24 : 33 7.
75. Sjo NC, Foegh P, Juhl BR et al. Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma. Ophthalmology 2007 114 : 182 6.
76. Lee SB, Yang JW, Kim CS. The association between conjunctival MALT lymphoma and Helicobacter pylori. Br J Ophthalmol 2008 92 : 534 6.
77. Goebel N, Serr A, Mittelviefhaus H et al. Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association? The German experience. Leuk Res 2007 31 : 1450 2.
78. Cohen VM, Sweetenham J, Singh AD. Ocular adnexal lymphoma. What is the evidence for an infectious aetiology? Br J Ophthalmol 2008 92 : 446 8.
79. Ferreri AJ, Viale E, Guidoboni M et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 2006 17 : 769 72.
80. Arcaini L, Burcheri S, Rossi A et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007 18 : 346 50.
81. Miyairi I, Byrne GI. Chlamydia and programmed cell death. Curr Opin Microbiol 2006 9 : 102 8.
82. Yeung L, Tsao YP, Chen PY et al. Combination of adult inclusion conjunctivitis and mucosa-associated lymphoid tissue (MALT) lymphoma in a young adult. Cornea 2004 23 : 71 5.
83. Lamb DJ, El-Sankary W, Ferns GA. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003 167 : 177 85.
84. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998 12 : 1255 65.
85. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 2003 362 : 469 76.
86. Ishii E, Yokota K, Sugiyama T et al. Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol 2001 8 : 1056 9.
87. Ferreri AJ, Ponzoni M, Guidoboni M et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005 23 : 5067 73.
88. Ferreri AJ, Ponzoni M, Guidoboni M et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst 2006 98 : 1375 82.
89. Ferreri AJ, Dognini G, Ponzoni M et al. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma. Ann Oncol 2008 19 : 194 5.
90. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001 48 : 297 303.
91. Ferreri AJ, Dolcetti R, Magnino S et al. A woman and her canary: a tale of chlamydiae and lymphomas. J Natl Cancer Inst 2007 99 : 1418 9.
92. Jelic S, Filipovic-Ljeskovic I. Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding? Hematol Oncol 1999 17 : 107 16.
93. Goodlad JR, Davidson MM, Hollowood K et al. Borrelia burgdorferi- associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Histopathology 2000 37 : 501 8.
94. Cerroni L, Zochling N, Putz B, Kerl K. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997 24 : 457 61.
95. Garbe C. [Borrelia infections of the skin - progress of knowledge since the discovery of Lyme disease]. Hautarzt 1991 42 : 356 65.
96. De La Fouchardiere A, Vandenesch F, Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. Am J Surg Pathol 2003 27 : 702 3.
97. Wood GS, Kamath NV, Guitart J et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001 28 : 502 7.
98. Goteri G, Ranaldi R, Simonetti O et al. Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association. Leuk Lymphoma 2007 48 : 2184 8.
99. Li C, Inagaki H, Kuo TT et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases. Am J Surg Pathol 2003 27 : 1061 9.
100. Schollkopf C, Melbye M, Munksgaard L et al. Borrelia infection and risk of non-Hodgkin lymphoma. Blood 2008 111 : 5524 9.
101. Tothova SM, Bonin S, Trevisan G, Stanta G. Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer 2006 94 : 879 83.
102. Picken RN, Strle F, Ruzic-Sabljic E et al. Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma. J Invest Dermatol 1997 108 : 92 7.
103. Kutting B, Bonsmann G, Metze D et al. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997 36 (2 Pt 2 311 4.
104. Roggero E, Zucca E, Mainetti C et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000 31 : 263 8.
105. Martin IG, Aldoori MI. Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease. Br J Surg 1994 81 : 20 4.
106. Lecuit M, Abachin E, Martin A et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004 350 : 239 48.
107. Akbulut H, Soykan I, Yakaryilmaz F et al. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Cancer 1997 80 : 8 14.
108. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med 2004 350 : 213 5.
109. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964 1 : 702 3.
110. Henle W, Henle G, Lennette ET. The Epstein-Barr virus. Sci Am 1979 241 : 48 59.
111. Farrell PJ, Bankier A, Seguin C et al. Latent and lytic cycle promoters of Epstein-Barr virus. EMBO J 1983 2 : 1331 8.
112. Murray RJ, Kurilla MG, Brooks JM et al. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 1992 176 : 157 68.
113. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990 55 : 133 270.
114. Geser A, De The G, Lenoir G et al. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 1982 29 : 397 400.
115. Takada K. Role of Epstein-Barr virus in Burkitt's lymphoma. Curr Top Microbiol Immunol 2001 258 : 141 51.
116. Komano J, Sugiura M, Takada K. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 1998 72 : 9150 6.
117. Kiss C, Nishikawa J, Takada K et al. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proc Natl Acad Sci USA 2003 100 : 4813 8.
118. Levine PH, Pallesen G, Ebbesen P et al. Evaluation of Epstein-Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease. Int J Cancer 1994 59 : 48 50.
119. Dukers DF, Jaspars LH, Vos W et al. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol 2000 190 : 143 9.
120. Spieker T, Kurth J, Kuppers R et al. Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virus-infected cells and Epstein-Barr virus-harboring Hodgkin and Reed/Sternberg cells in Hodgkin disease. Blood 2000 96 : 3133 8.
121. Langerak AW, Moreau E, Van Gastel-Mol EJ et al. Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool. Leukemia 2002 16 : 1572 3.
122. Drouet E, Brousset P, Fares F et al. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J Med Virol 1999 57 : 383 9.
123. Axdorph U, Porwit-Macdonald A, Sjoberg J et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999 81 : 1182 7.
124. Morente MM, Piris MA, Abraira V et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997 90 : 2429 36.
125. Murray PG, Billingham LJ, Hassan HT et al. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999 94 : 442 7.